Use of glargine in pregnant women with Type 1 diabetes mellitus: A case-control study

Clinical Therapeutics

Volumn 30, Issue 8, 2008, Pages 1476-1484

  Imbergamo, Maria P ^a   Amato, Marco C ^a   Sciortino, Giovanna ^a   Gambina, Massimo ^a   Accidenti, Maria ^a   Criscimanna, Angela ^a   Giordano, Carla ^a   Galluzzo, Aldo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

diabetes type 1; glargine; neonatal outcome; pregnancy

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

ABDOMEN; ADD ON THERAPY; ADULT; APGAR SCORE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONGENITAL DISORDER; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEMUR; FETUS ECHOGRAPHY; FETUS GROWTH; FETUS MONITORING; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEAD CIRCUMFERENCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INSULIN TREATMENT; ITALY; LARGE FOR GESTATIONAL AGE; MATERNAL DISEASE; MATERNAL HYPERTENSION; MICROALBUMINURIA; NEONATAL RESPIRATORY ADAPTATION; NEWBORN HYPOCALCEMIA; NEWBORN HYPOGLYCEMIA; NEWBORN JAUNDICE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; RESPIRATORY DISTRESS SYNDROME; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SIDE EFFECT; SMALL FOR DATE INFANT; THIRD TRIMESTER PREGNANCY;

ADULT; BLOOD GLUCOSE; BODY WEIGHTS AND MEASURES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FEMUR; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, ISOPHANE; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 51549106264     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.08.013     Document Type: Article

References (36)

1. Bolli G.B., and Owens D.R. Insulin glargine. Lancet 356 (2000) 443-445
2. Ratner R.E., Hirsch I.B., Neifing J.L., et al., for the US Study Group of Insulin Glargine in Type 1 Diabetes. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 23 (2000) 639-643
3. Albright E.S., Desmond R., and Bell D.S. Efficacy of conversion from bedtime NPH insulin injection to once- or twicedaily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy. Diabetes Care 27 (2004) 632-633
4. Jensen D.M., Damm P., Moelsted-Pedersen L., et al. Outcomes in type 1 diabetic pregnancies: A nationwide, population-based study. Diabetes Care 27 (2004) 2819-2823
5. American Diabetes Association. Preconception care of women with diabetes. Diabetes Care 27 Suppl 1 (2004) S76-S78
6. Suhonen L., Hiilesmaa V., and Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type 1 diabetes mellitus. Diabetologia 43 (2000) 79-82
7. Lapolla A., Dalfrà M.G., and Fedele D. Insulin therapy in pregnancy complicated by diabetes: Are insulin analogs a new tool?. Diabetes Metab Res Rev. 21 (2005) 241-252
8. Slieker L.J., Brooke G.S., DiMarchi R.D., et al. Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-1 receptor more than for the insulin receptor. Diabetologia 40 Suppl 2 (1997) S54-S61
9. Stammberger I., Bube A., Durchfeld-Meyer B., et al. Evaluation of carcinogenic potential of insulin glargine (LANTUS) in rats and mice. Int J Toxicol. 21 (2002) 171-179
10. Hofmann T., Horstmann G., and Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits. Int J Toxicol. 21 (2002) 181-189
11. Holstein A., Plaschke A., and Egberts E.H. Use of insulin glargine during embryogenesis in a pregnant woman with type 1 diabetes. Diabet Med. 20 (2003) 779-780
12. Devlin J.T., Hothersall L., and Wilkis J.L. Use of insulin glargine during pregnancy in a type 1 diabetic woman. Diabetes Care 25 (2002) 1095-1096
13. Dolci M., Mori M., and Baccetti F. Use of glargine insulin before and during pregnancy in a woman with type 1 diabetes and Addison's Disease. Diabetes Care 28 (2005) 2084-2085
14. Di Cianni G., Volpe L., Lencioni C., et al. Use of insulin glargine during the first weeks of pregnancy in five type 1 diabetic women. Diabetes Care 28 (2005) 982-983
15. Torlone E., Gennarini A., Ricci N.B., and Bolli G.B. Successful use of insulin glargine during entire pregnancy until delivery in six type 1 diabetic women. Eur J Obstet Gynecol Reprod Biol. 132 (2007) 238-239
16. Price N., Bartlett C., and Gillmer M.D. Use of insulin glargine during pregnancy: A case-control pilot study. BJOG 114 (2007) 453-457
17. Woolderink J.M., van Loon A.J., Storm S.F., et al. Use of insulin glargine during pregnancy in seven type 1 diabetic women. Diabetes Care 28 (2005) 2594-2595
18. Singh C., and Jovanovic L. Insulin analogues in the treatment of diabetes in pregnancy. Obstet Gynecol Clin North Am. 34 (2007) 275-291
19. Singh C., and Jovanovic L. Insulin analogues in the treatment of diabetes in pregnancy. Obstet Gynecol Clin North Am. 34 (2007) ix
20. Gallen I.W., Jaap A., Roland J.M., and Chirayath H.H. Survey of glargine use in 115 pregnant women with type 1 diabetes. Diabet Med. 25 (2008) 165-169
21. Tahrani A.A., Varughese G.I., Wilkins J.D., et al. Glargine in pregnant patients with type 1 diabetes. Diabet Med. 25 (2008) 111-112
22. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 31 Suppl 1 (2008) S12-S54
23. Parazzini F., Cortinovis I., Bortolus R., and Fedele L. Standard di peso alla nascita in Italia. Ann Ost Gin Med Perin. CXII (1991) 203-246
24. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg. 32 (1953) 260-267
25. Bailar III J.C., and Mosteller F. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. Ann Intern Med. 108 (1988) 266-273
26. Lauria L., and Saporito M. Comparison of stillbirth and neonatal mortality in two Italian regions: Lombardia and Campania [in Italian]. Epidemiol Prev. 28 (2004) 217-224
27. Drexel H., Bichler A., Sailer S., et al. Prevention of perinatal morbidity by tight metabolic control in gestational diabetes mellitus. Diabetes Care 11 (1988) 761-768
28. Gabbe S.G., Carpenter L.B., and Garrison E.A. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clin Obstet Gynecol. 50 (2007) 1014-1024
29. Yki-Järvinen H., Dressler A., Ziemen M., and for the HOE 901/3002 Study Group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 23 (2000) 1130-1136
30. Witthaus E., Stewart J., and Bradley C. Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with type 1 diabetes. Diabet Med 18 (2001) 619-625
31. Catalano P.M., Tyzbir E.D., Roman N.M., et al. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 165 (1991) 1667-1672
32. Catalano P.M., Huston L., Amini S.B., and Kalhan S.C. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol. 180 (1999) 903-916
33. Buchanan T.A., Metzger B.E., Freinkel N., and Bergman R.N. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 162 (1990) 1008-1014
34. Di Cianni C., Miccoli R., Volpe L., et al. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev. 19 (2003) 259-270
35. Ryan E.A., and Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 67 (1988) 341-347
36. Temple R.C., Aldridge V.J., and Murphy H.R. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 29 (2006) 1744-1749